Prostate-specific antigen levels among cirrhotic patients

International Journal of Biological Markers

Volumn 17, Issue 3, 2002, Pages 161-164

  Akdogan, Meral ^a   Hassoun, B S ^a   Gurakar, A ^a   El Sahwi, K ^a   Jazzar, A ^a   Wright, H ^a   Sebastian, A ^a   Nour, B ^a  

^a Ufuk Apt 138/17 ^*  (Turkey)

Author keywords

Liver cirrhosis; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DIGITAL RECTAL EXAMINATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HUMAN; INTESTINE EXAMINATION; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NORMAL VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RECTUM BIOPSY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0036662557     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080201700303     Document Type: Article

References (15)

1. Carter HB, Partin AW. Diagnosis and staging of prostate cancer. In: Walsh PC, Retik AB, Vaughan ED, Wein AS, eds. Campbell's Urology, 7th ed. Philadelphia: WB Saunders Company, 1998; 2519-37.
2. Ahga AH, Schechter E, Roy JB, et al. Prostate specific antigen is metabolized in the liver. J Urol 1996; 155: 1332-5.
3. Van Thiel DH, Gavaler JS, Spero JA, et al. Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies. Hepatology 1981; 1: 39-46.
4. Wang YJ, Wu JC, Lee SD, et al. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepato-Gastroenterol 1991; 38: 531-4.
5. Wang YJ, Lee SD, Lin HC, et al. Changes of sex hormone levels in patients with hepatitis B virus-related postnecrotic cirrhosis: relationship to the severity of portal hypertension. J Hepatol 1993; 18: 101-5.
6. Henderson JM. Surgical management of portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the liver. Philadelphia: Lippincott-Raven Publishers, 1999; 443-52.
7. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860-4.
8. Cetinkaya M, Cetinkaya H, Ulusoy E, et al. Effect of post-necrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia. Prostate 1998; 36: 80-4.
9. Jin B, McCaughan GW, Handelsman DJ. Effects of liver disease and transplantation on the human prostate. J Androl 1999; 20: 559-65.
10. van Kesteren P, Meinhardt W, van der Valk P, et al. Effects of estrogens only on prostates of aging men. J Urol, 1996; 156: 1349-53.
11. Williams PB, Eastham JA, Culkin DJ, et al. Influence of hepatic function on serum levels of prostate specific antigen. J Urol 1997; 158: 1867-9.
12. Kilic S, Guntekin E, Danisman A, et al. Serum free and total prostate-specific antigen levels in patients with liver disease. Urology 1998; 52: 825-7.
13. Frea B, Annoscia S, Stanta G, et al. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study. Urol Res 1987; 15: 311-4.
14. Black MH, Diamandis EP. The diagnosis and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 2000; 59: 1-14.
15. Gavaler JS, Van Thiel DH. Gonadal dysfunction and inadequate sexual performance in alcoholic cirrhotic men. Gastroenterology 1988; 95: 1680-3.